2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Parotid Neoplasms: new trials by email Literature Review of Parotid Neoplasms trials Research Report on Parotid Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery Bevonescein - Parotid Neoplasm, Thyroid Neoplasms | Phase 1 / Phase 2 | Completed | Alume Biosciences, Inc. | 27 | 2020-06-18 | 2025-05-08 |
| Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer Cisplatin, Docetaxel, Bevacizumab - Head and Neck Cancer, Parotid Gland Cancer | Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 13 | 2006-12-01 | 2025-05-06 |
Head and Neck Neoplasms (2) · Thyroid Neoplasms (2) · Melanoma (1)
Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Mouth Diseases (2) · Mouth Neoplasms (2) · Neoplasms (2) · Neoplasms by Site (2) · Parotid Diseases (2) · Salivary Gland Diseases (2) · Salivary Gland Neoplasms (2) · Stomatognathic Diseases (2) · Thyroid Diseases (2) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Nerve Tissue (1) · Neuroectodermal Tumors (1)
Bevacizumab (1) · Cisplatin (1) · Docetaxel (1) · Erlotinib Hydrochloride (1) · Radiation (1) · Radiotherapy (1)
Alume Biosciences, Inc. (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)
United States (2)